State Of Wyoming Travere Therapeutics, Inc. Transaction History

State Of Wyoming

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$20.94 - $30.01 $24,499 - $35,111	-1,170 Reduced 80.63%	281 $7,000
Q1 2022 May 13, 2022	SELL	$23.61 - $30.6 $10,955 - $14,198	-464 Reduced 24.23%	1,451 $37,000
Q4 2021 Feb 11, 2022	BUY	$24.34 - $31.17 $16,356 - $20,946	672 Added 54.06%	1,915 $59,000
Q3 2021 Feb 11, 2022	BUY	$12.98 - $25.03 $10,137 - $19,548	781 Added 169.05%	1,243 $30,000
Q2 2021 Feb 11, 2022	BUY	$14.11 - $26.4 $6,518 - $12,196	462 New	462 $7,000

192

84.5M

776K

900K

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.12B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.